677004-45-4Relevant academic research and scientific papers
SOLUBLE GUANYLATE CYCLASE STIMULATORS
-
Paragraph 0886; 0887, (2017/07/14)
The invention provides compounds of the Formula (I) or a pharmaceutically acceptable salts thereof, wherein X, Y, Z, R1, R2, R4, Ra, and the subscripts m, p, and q are as described herein. The compounds or their
3-HETEROARYL SUBSTITUTED INDAZOLES
-
Page/Page column 119; 120; 121, (2014/10/03)
Compounds of formula (I) which are inhibitors of Bub1 kinase, processes for their production and their use as pharmaceuticals.
SUBSTITUTED BENZYLINDAZOLES FOR USE AS BUB1 KINASE INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES.
-
Page/Page column 132; 133, (2013/04/24)
Compounds of formula (I) which are inhibitors of Bub1 kinase, processes for their production and their use as pharmaceuticals.
MORPHOLINE-BRIDGED INDAZOLE DERIVATIVES
-
Page/Page column 32, (2008/06/13)
The invention relates to novel morpholine-bridged indazole derivatives which stimulate soluble guanylate cyclase, to methods for the production thereof and to the use of the same for producing medicaments, especially medicaments for treating diseases of the central nervous system.
